Literature DB >> 17384441

Characteristics and outcomes of patients with heart failure in general practices and hospitals.

Hiroyuki Tsutsui1, Miyuki Tsuchihashi-Makaya, Shintaro Kinugawa, Daisuke Goto, Akira Takeshita.   

Abstract

BACKGROUND: The characteristics and outcomes of patients discharged from hospitals with a diagnosis of heart failure (HF) have been described by a number of previous epidemiological studies. However, very little information is available on this issue in general practice in Japan. METHODS AND
RESULTS: The Japanese Cardiac Registry of Heart Failure in General Practice (JCARE-GENERAL) is designed to study the characteristics, treatment and outcomes prospectively in a broad sample of outpatients with HF who were managed by cardiologists in hospital (Hospital-HF) and primary care physicians in general practice (GP-HF). Out of 2,685 patients with HF, 1,280 patients were Hospital-HF and 1,405 GP-HF. Compared to the Hospital-HF patients, GP-HF patients were more likely to be elderly and female, and they had a higher prevalence of hypertensive heart disease as a cause of HF. Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and beta-blockers were more prescribed to Hospital-HF than GP-HF patients. At the follow-up of 1.2 year, after adjustment, the mortality was comparable between the Hospital-HF and GP-HF groups, whereas HF-related admission was higher in the Hospital-HF group than in in the GP-HF group.
CONCLUSIONS: Based on the JCARE-GENERAL, the characteristics, treatment and outcomes of GP-HF patients differed from those of Hospital-HFpatients in Japan.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384441     DOI: 10.1253/circj.71.449

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  16 in total

1.  Pattern of use of β-blockers in older patients with stable coronary artery disease: an observational, cross-sectional, multicentre survey.

Authors:  Cristiana Vitale; Ilaria Spoletini; Maurizio Volterrani; Ferdinando Iellamo; Massimo Fini
Journal:  Drugs Aging       Date:  2011-09-01       Impact factor: 3.923

2.  Efficacy and safety of the early use of V2 receptor antagonists in elderly patients with decompensated heart failure.

Authors:  Ryuichi Matsukawa; Toru Kubota; Masanori Okabe; Yusuke Yamamoto; Hiroshi Meno
Journal:  Heart Vessels       Date:  2017-08-16       Impact factor: 2.037

3.  Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.

Authors:  Changhai Tian; Lie Gao; Matthew C Zimmerman; Irving H Zucker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

4.  Early use of V2 receptor antagonists is associated with a shorter hospital stay and reduction in in-hospital death in patients with decompensated heart failure.

Authors:  Ryuichi Matsukawa; Toru Kubota; Masanori Okabe; Yusuke Yamamoto
Journal:  Heart Vessels       Date:  2015-12-16       Impact factor: 2.037

5.  Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria.

Authors:  Yoshimori An; Kenji Ando; Yoshimitsu Soga; Akihiro Nomura; Michio Nagashima; Kentaro Hayashi; Yu Makihara; Masato Fukunaga; Ken-Ichi Hiroshima; Masakiyo Nobuyoshi; Masahiko Goya
Journal:  J Arrhythm       Date:  2016-06-28

Review 6.  Heart failure in East Asia.

Authors:  Yutao Guo; Gregory Y H Lip; Amitava Banerjee
Journal:  Curr Cardiol Rev       Date:  2013-05

7.  Secular trends in the etiology and comorbidity of hospitalized patients with congestive heart failure: A single-center retrospective study.

Authors:  Zhi-Yong Pei; Yu-Sheng Zhao; Jia-Yue Li; Qiao Xue; Lei Gao; Shi-Wen Wang
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

Review 8.  Chronic heart failure in Japan: implications of the CHART studies.

Authors:  Nobuyuki Shiba; Hiroaki Shimokawa
Journal:  Vasc Health Risk Manag       Date:  2008

9.  Mechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expression.

Authors:  Chunyan Yang; Zhonghui Liu; Kai Liu; Ping Yang
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

Review 10.  Heal the heart through gut (hormone) ghrelin: a potential player to combat heart failure.

Authors:  Shreyasi Gupta; Arkadeep Mitra
Journal:  Heart Fail Rev       Date:  2020-10-06       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.